The Thai Surgical Intensive Care Study (Thai-SICU Study)

Royal College of Anesthesiologists of Thailand4,652 enrolled

Overview

The study observed the 28 days mortality of 9 participated University base surgical intensive care unit (SICU) as well as the occurrence of adverse events in SICU.

The adverse events included pulmonary aspiration, pulmonary emboli, drug error, new stroke, symptomatic deep vein thrombosis, pneumothorax, unplanned extubation, upper GI hemorrhage, myocardial infarction, abdominal hypertension, acute lung injury(ALI)/acute respiratory distress syndrome (ARDS), re-intubation within 72 hours, delirium, cardiac arrest, new arrhythmia, acute kidney injury, sepsis

Study Type

OBSERVATIONAL

Enrollment

4,652

Conditions

Complications of Surgical and Medical Care: General Terms Adverse Reaction to Drug Sequelae of External Causes of Morbidity and Mortality Critical Illness

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All SICU admission patients Exclusion Criteria: * Age \< 18 years

Locations (9)

Department of Surgery and Department of Anesthesiology, Bangkok metropolitan medical college and Vajira hospital

Bangkok, Bangkok, Thailand

Department of Anesthesiology, Faculty of Medicine, Chulalongkorn hospital

Bangkok, Bangkok, Thailand

Department of Anesthesiology, Faculty of Medicine, Ramathibodi hospital

Bangkok, Bangkok, Thailand

Outcomes

Primary Outcomes

Overall Mortality

Number of Participants who Did Not Survive up to 28 days after surgical ICU admission

Time frame: 28 days

Secondary Outcomes

Readmission to ICU

Number of Participants with Readmission to ICU up to 3 days (72 hours) after discharge from ICU

Time frame: 3 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.